Article Abstract

Metformin: a potentially winning therapeutic strategy to prevent breast cancer progression in overweight postmenopausal patients

Authors: Danila Coradini

Abstract

Growing body of literature supports the evidence that, in postmenopausal women, breast cancer initiation and progression are close associated with a series of interconnected factors which include weight gain, metabolic syndrome and increase of circulating androgens.